A5019447892- Venous Thromboembolism Diagnosis and Management
- Pulmonary Hypertension Research and Treatments
- Acute Myocardial Infarction Research
- Cardiac Imaging and Diagnostics
- Heart Failure Treatment and Management
- Atrial Fibrillation Management and Outcomes
- Cardiovascular Function and Risk Factors
- Coronary Interventions and Diagnostics
- Lipoproteins and Cardiovascular Health
- Takotsubo Cardiomyopathy and Associated Phenomena
- Acute Ischemic Stroke Management
- Cardiac Valve Diseases and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Structural Anomalies and Repair
- Cardiac Health and Mental Health
- Pericarditis and Cardiac Tamponade
- Cardiac, Anesthesia and Surgical Outcomes
- COVID-19 and healthcare impacts
- Coronary Artery Anomalies
- COVID-19 Clinical Research Studies
- Blood Pressure and Hypertension Studies
- Cardiovascular Issues in Pregnancy
- Dialysis and Renal Disease Management
- Cardiovascular and exercise physiology
- Central Venous Catheters and Hemodialysis
Medical University of Warsaw
2016-2025
British Heart Foundation
2022
University of Leeds
2022
University of Warsaw
2008
Wojskowy Instytut Medyczny
2006
There is a growing clinical and scientific interest in catheter-directed therapy (CDT) of acute pulmonary embolism (PE). Currently, CDT should be considered for patients with high-risk PE, whom thrombolysis contraindicated or has failed. Also, treatment option initially stable anticoagulant fails, i.e., those who experience haemodynamic deterioration despite adequately dosed anticoagulation. However, the definition failure (primary reperfusion anticoagulation alone) remains an important area...
The current treatment algorithm for chronic thromboembolic pulmonary hypertension (CTEPH) as depicted in the 2022 European Society of Cardiology (ESC)/European Respiratory (ERS) guidelines on diagnosis and (PH) includes a multimodal approach combinations endarterectomy (PEA), balloon angioplasty (BPA) medical therapies to target major vessel vascular lesions, microvasculopathy. Today, BPA >1700 patients has been reported literature from centers Asia, US, also Europe; many more have treated...
Balloon pulmonary angioplasty (BPA) is a promising therapy for patients with chronic thromboembolic hypertension (CTEPH) who are ineligible endarterectomy.The present study aimed to evaluate the safety and efficacy of BPA CTEPH using first multicentre registry single European country.Data were obtained from Database Pulmonary Hypertension in Polish Population (NCT03959748), prospective, adult paediatric arterial (PAH) CTEPH, total 236 confirmed (124 women; mean age 67 years) underwent 1,056...
Significant achievements in the treatment of chronic thromboembolic pulmonary hypertension (CTEPH) have provided effective therapeutic options for most patients. However, true impact changed landscape CTEPH therapies on patients' management and outcomes is poorly known. We aimed to characterize incidence, clinical characteristics, patients modern era therapies.We analyzed data adults enrolled prospective multicenter registry.We 516 aged 63.8 ± 15.4 years. The incidence rate was 3.96 per...
A pulmonary embolism response team (PERT) is a multidisciplinary established to improve clinical care for patients with (PE). However, data regarding detailed institutional experience and outcomes from such teams are sparse.We aim assess the frequency of activations, patients' characteristics, PE severity, applied treatments, treated by Polish PERTs.The survey registry was conducted between June 2018 July 2020. All consecutive PERT activations four institutionalized PERTs in Poland were...
Thanks to advances in interventional cardiology technologies, catheter-directed treatment has become recently a viable therapeutic option the of patients with acute pulmonary embolism at high risk early mortality. Current transcatheter techniques allow for local fibrinolysis or embolectomy minimal complications. Therefore, these procedures can be considered high-risk as an alternative surgical when systemic thrombolysis is contraindicated ineffective. They are also intermediate-high-risk who...
Thanks to advances in interventional cardiology technologies, catheter-directed treatment has become recently a viable therapeutic option the of patients with acute pulmonary embolism at high risk early mortality. Current transcatheter techniques allow for local fibrinolysis or embolectomy minimal complications. Therefore, these procedures can be considered high-risk as an alternative surgical when systemic thrombolysis is contraindicated ineffective. They are also intermediate-high-risk who...
Background: The primary role of a pulmonary embolism response team (PERT) is to support decision-making processes regarding acute (PE) patients and provide advanced rescue therapies when needed. Despite great need for its availability among physicians, PERT’s usefulness yet be proven. Objectives: Our goal was establish whether benefit from qualification by PERT admission tertiary cardiology ward. Methods: Data all hospitalized due PE 12 months (July 2023–June 2024) were retrospectively...
Data on interventional treatment of intermediate-high (and high-risk pulmonary embolism (PE) are limited. The authors sought to evaluate the safety and efficacy catheter-directed mechanical aspiration thrombectomy (CDMT) in a real-world PE patient population. This multicenter, prospective registry enrolled patients treated with CDMT using Lightning 12 System. primary endpoints included in-hospital all-cause mortality, procedure-related major bleeding, clinical deterioration, or bailout...
Cardiovascular diseases are the leading cause of morbidity and mortality in patients with end-stage renal disease.
Pulmonary Embolism Response Team (PERT) is a multidisciplinary team established to stratify risk and choose optimal treatment in patients with acute pulmonary embolism (PE). Established for the first time at Massachusetts General Hospital 2013, PERT based on concept combining Rapid Heart Team. The growing role of PERTs making individual therapeutic decisions identified, especially hemodynamically unstable contraindications thrombolysis or co-morbidities, as well intermediate-high whom...
Radial access is a standard approach for coronary interventions. However, it carries some risk of local or long-term complications such as hematoma radial artery occlusion.To assess the feasibility very distal left and right transradial (VITRO) interventions.Three hundred twenty consecutive patients were submitted to diagnostic therapeutic In 102 was not palpable pulse too weak. 218 selected (142 male, 76 female, age: 69 ±11 years) we decided perform approach.The VITRO suitable in 195 with...
Introduction/Objectives Balloon pulmonary angioplasty (BPA) is a developing treatment for inoperable chronic thromboembolic hypertension (CTEPH). However, to our knowledge there are no published data on BPA in CTEPH subjects aged 75 or over. The aim of the study was analyze clinical and hemodynamic outcomes sequential very elderly patients disqualified from endarterectomy (PEA). Patients Methods We enrolled 10 (4 male, 6 female, median age 81 [75‐88]) with confirmed CTEPH, mPAP > 30 mmHg,...
Background: The aim of this study was to evaluate the usefulness a novel clinical score — InterTAK Diagnostic Score in differentiating Takotsubo syndrome (TTS) from acute coronary (ACS). Methods: Medical records 40 consecutive patients with ACS and 20 TTS were managed retrospectively analyzed at documented center. Each patient evaluated using Inter- TAK Score. To illustrate diagnostic ability score, receiver operating characteristic (ROC) curve performed. Results: Takotsube more often female...
A number of medications such as beta-blockers,ACE-inhibitors, angiotensin receptor blockers and aldosterone antagonists, improve survival in patients with heart failure (HF) reduced ejection fraction. No therapy has been proved to be beneficial for preserved fraction (PLVEF).The aim the study was assess effect statin on all-cause mortality cardiovascular rehospitalization rate HF PLVEF during one-year follow-up.We evaluated 146 (ejection > or = 45%). Patients were divided into group (n 103,...
Takotsubo cardiomyopathy (TTC) is a rare transient mimicking acute coronary syndrome (ACS).The aim of the study was to retrospectively analyze clinical course, treatment strategies, and follow-up patients with TTC.Among all hospitalized in department between January 2005 2010, we identified group who were fulfilling modified Mayo Clinic criteria for diagnosis TTC. Clinical presentation, hospital outcomes analyzed.A total 31 TTC included into study; women comprised 93.5% population. The most...